Centerstone CEO Testifies on Opioid Crisis before Congressional Committee
Published: Monday, May 21, 2018 4:22 pm
Today, the House Subcommittee on Health will conclude "Combating the Opioid Crisis: Improving the Ability of Medicare and Medicaid to Provide Care For Patients," a series of hearings to uncover solutions to growing opioid abuse across the U.S. David C. Guth, Jr., CEO of Centerstone, will participate in one of the final sessions of the hearings: a panel of five behavioral health leaders discussing the nation's ability to use its current resources to treat and care for those with opioid use disorder.
"It is an honor to be given the opportunity to address the Subcommittee on Health as it explores how our country can better address the opioid epidemic and support those in need of treatment for addiction," said Guth. "My colleagues and I are grateful that Congress has so thoughtfully explored this issue, and we look forward to working with our elected officials on implementing solutions to ensure that everyone who seeks treatment - regardless of where they live - has access to the best possible, most comprehensive care."
Guth's testimony recommended policy changes aimed at improving three areas in the fight against the opioid crisis:
As one of the nation's hundreds of behavioral health providers, Centerstone understands the challenges of the underdeveloped workforce in the industry that is also underequipped to take on this crisis. However, the organization knows the importance of implementing a standard for comprehensive addiction treatment and supports the Subcommittee on Health's consideration of its 34-bill package that would amend Medicaid and Medicare programs.
Guth's full testimony can be found here.